• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Nephrolithiasis in patients exposed to deferasirox and desferioxamine: probably an age-linked event with different effects on some renal parameters.

作者信息

Ricchi Paolo, Ammirabile Massimiliano, Costantini Silvia, Spasiano Anna, Di Matola Tiziana, Cinque Patrizia, Casale Maddalena, Filosa Aldo, Prossomariti Luciano

机构信息

UOSD Centro delle Microcitemie "A. Mastrobuoni", AORN A. Cardarelli, Naples, Italy,

出版信息

Ann Hematol. 2014 Mar;93(3):525-7. doi: 10.1007/s00277-013-1833-y. Epub 2013 Jun 27.

DOI:10.1007/s00277-013-1833-y
PMID:23807253
Abstract
摘要

相似文献

1
Nephrolithiasis in patients exposed to deferasirox and desferioxamine: probably an age-linked event with different effects on some renal parameters.接受地拉罗司和去铁胺治疗的患者发生肾结石：可能是一种与年龄相关的事件，对某些肾脏参数有不同影响。
Ann Hematol. 2014 Mar;93(3):525-7. doi: 10.1007/s00277-013-1833-y. Epub 2013 Jun 27.
2
Nephrolithiasis in beta thalassemia major patients treated with deferasirox: an advent or an adverse event? A single Greek center experience.接受地拉罗司治疗的重型β地中海贫血患者的肾结石：是偶然现象还是不良事件？希腊单一中心经验
Ann Hematol. 2013 Jan;92(2):263-5. doi: 10.1007/s00277-012-1558-3. Epub 2012 Aug 30.
3
Nephrolithiasis in two patients on iron chelation therapy: A case report.两名铁螯合治疗患者的肾结石病：病例报告。
Transfus Apher Sci. 2023 Jun;62(3):103702. doi: 10.1016/j.transci.2023.103702. Epub 2023 Mar 11.
4
Daily alternating deferasirox and deferiprone therapy for "hard-to-chelate" beta-thalassemia major patients.每日交替使用地拉罗司和去铁酮疗法治疗“难以螯合”的重型β地中海贫血患者。
Am J Hematol. 2010 Jun;85(6):460-1. doi: 10.1002/ajh.21711.
5
Incidence of ototoxicity in pediatric patients with transfusion-dependent thalassemia who are less well-chelated by mono- and combined therapy of iron chelating agents.接受铁螯合剂单药及联合治疗但螯合效果欠佳的输血依赖型地中海贫血患儿的耳毒性发生率。
Hemoglobin. 2014;38(5):345-50. doi: 10.3109/03630269.2014.940462. Epub 2014 Jul 22.
6
Incidence of deferasirox-associated renal tubular dysfunction in children and young adults with beta-thalassaemia.地拉罗司相关肾小管功能障碍在儿童和年轻成人β地中海贫血患者中的发生率。
Br J Haematol. 2014 Nov;167(3):434-6. doi: 10.1111/bjh.13002. Epub 2014 Jul 2.
7
Deferasirox effect on renal haemodynamic parameters in patients with transfusion-dependent β thalassaemia.地拉罗司对依赖输血的β地中海贫血患者肾脏血流动力学参数的影响。
Br J Haematol. 2015 Mar;168(6):882-90. doi: 10.1111/bjh.13217. Epub 2014 Nov 17.
8
Renal dysfunction in patients with beta-thalassemia major receiving iron chelation therapy either with deferoxamine and deferiprone or with deferasirox.接受去铁胺和地拉罗司或去铁酮螯合铁治疗的重型β地中海贫血患者的肾功能障碍。
Acta Haematol. 2010;123(3):148-52. doi: 10.1159/000287238. Epub 2010 Feb 24.
9
Correlation of iron overload and glomerular filtration rate estimated by cystatin C in patients with β-thalassemia major.重型β地中海贫血患者中铁过载与胱抑素C估算的肾小球滤过率的相关性
Hemoglobin. 2014;38(5):365-8. doi: 10.3109/03630269.2014.944314. Epub 2014 Jul 30.
10
Oral iron chelation therapy for thalassaemia: an uncertain scene.地中海贫血的口服铁螯合疗法：前景不明。
Br J Haematol. 2000 Oct;111(1):2-5. doi: 10.1046/j.1365-2141.2000.02406.x.

引用本文的文献

1
Renal Findings in Patients with Thalassemia at Abdominal Ultrasound: Should We Still Talk about "Incidentalomas"? Results of a Long-Term Follow-Up.地中海贫血患者腹部超声检查中的肾脏表现：我们是否仍应提及“偶发瘤”？一项长期随访结果
Diagnostics (Basel). 2024 Sep 15;14(18):2047. doi: 10.3390/diagnostics14182047.
2
Juvenile erythrocytosis in children after liver transplantation: prevalence, risk factors and outcome.儿童肝移植后幼年性红细胞增多症：患病率、危险因素和结局。
Sci Rep. 2020 Jun 16;10(1):9683. doi: 10.1038/s41598-020-66586-6.
3
Deferoxamine therapy for intracerebral hemorrhage: A systematic review.
去铁胺治疗脑出血：系统评价。
PLoS One. 2018 Mar 22;13(3):e0193615. doi: 10.1371/journal.pone.0193615. eCollection 2018.